AURO-ZIPRASIDONE

auro pharma inc🇨🇦 Health Canada

Approval Id: f680f6cd370bf562
Drug Approval Canada Name: AURO-ZIPRASIDONE
Product Name: AURO-ZIPRASIDONE
Status: Marketed
Status Date: 2018-03-19
Original Market Date: 2018-03-19
Din: 02449579
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.08.04
Atc Original: N05AE04 ZIPRASIDONE
Atc Name: n 05 ae 04
Aig Number: 0152272004
Company Name: auro pharma inc
Company Address: 3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8

ZIPRASIDONE (ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE)

80 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f680f6cd370bf562

Type

Standard